Wajd Life Stock: price and insider trades · Saudi Arabia
Wajd Life: what insiders have been doing
We have very little insider data for Wajd Life so far: the most recent filing dates from 10 November 2025. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by Tadawul (CMA). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 24,335 of 26,913 companies
21.3
score / 100
Value21
Quality22
FCF yld-46%
Earn yld-6.1%
EV/EBITDA13.6x
ROE-8.0%
Gross mgn25%
Net mgn-4.2%
Debt/EBITDA6.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SAR 4.70
Analyst consensus
Income statement
RevenueSAR 84.9M
Gross profitSAR 21.3M25% margin
EBITDASAR 8.2M10% margin
Net income-SAR 3.6M-1.8% margin
Valuation
P/Book2.2x
Balance sheet & cash
Market capSAR 58.7M
Total debtSAR 52.7M
Free Cash Flow-SAR 26.9M
Debt / Equity175%
Profitability & ownership
ROE-8.0%
ROA4.8%
% insiders100.0%
Last declaration on 10 November 2025
Declarations1 total
- ●Executives0Tadawul
1 of 1 declaration
About Wajd Life
Wajd Life is a company focused on the health and pharmaceutical sector. It is listed on the XSAU market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations